New Medicare Drug Pay Model Invites Industry Clash

Federal regulators on Tuesday proposed a nationwide, five-year test of new drug payment policies aimed at cutting costs in Medicare Part B, likely touching off a significant fight with drugmakers, doctors...

Already a subscriber? Click here to view full article